How AGAH works
The up to 20 regents ensure that the challenging workload of the Association remains achievable without taking up too much time.
The general meeting of AGAH elects the regents and board and decides the orientation of the Association. The Association's projects are determined by the general meeting and/or the regents.
AGAH has a modern, democratic and flexible management model that has proven to work very well.Dynamism, modernity of the subjects, integration of young scientists – no empty words at AGAH, but instead established practice.
The Association is supported in organisational terms by a professional office, which also makes the many activities practically possible.
Organisation
The board of AGAH comprises five members,
- President
- Past President
- President Elect
- Treasurer
- Secretary
A new President Elect is elected every two years and the other Presidents move to their next office or leave the board.
This ensures that the board is constantly renewed but also that there is sufficient continuity through board membership of 6 years in total of the Presidents in order to guarantee high quality work by the board thanks to sufficient experience.
Current board members
President
Dr. med. vet. Joachim Höchel
Bayer AG
Müllerstraße 178
13353 Berlin
Past President
Dr. med. Sybille Baumann MD
CRS Clinical Research Services Berlin GmbH
Sellerstraße 31 Gebäude P300
13353 Berlin
President Elect
Dr. med. Jörg Täubel, MD FFPM FESC
St George's University of London
Cranmer Terrace
Tooting
London SW17 0RE
UNITED KINGDOM
Treasurer
André Warnke
SocraTec R&D GmbH
Im Setzling 35
61440 Oberursel
Secretary
Nadja Faißt
CRS Clinical Research Services Mannheim GmbH
Grenadierstraße 1
68167 Mannheim
Regents
apl. Prof. Dr. med. Antje Blank
Head Pharmacology Early Clinical Trial Unit
Heidelberg University Hospital - Dept. Internal Medicine
Clinical Pharmacology and Pharmaepidemiology
Im Neuenheimer Feld 410
69120 Heidelberg
Ruwen Böhm
SocraTec R&D GmbH
Mainzerhofplatz 14
99084 Erfurt
Dr. rer. nat. Rolf Burghaus
Research & Development, Pharmaceuticals Systems Pharmacology & Medicine
Bayer AG
Building 0431
42096 Wuppertal
Dr. Martin Coenen
Studienzentrale & Phase I-Einheit, Studienzentrum Bonn
Institut für Klinische Chemie und Klinische Pharmakologie, Universitätsklinikum Bonn
Sigmund-Freud-Straße 25
53127 Bonn
Dr. med. Katharina Erb-Zohar
Clinical Pharmacologist
clinphase®
Schotten
Dr. med. vet. Daniela Guckelberger
Consultant
PreClinical Safety (PCS) Consultants Ltd
Nauenstraße 49
4052 Basel
Switzerland
Klaus Francke
Research & Development, Pharmaceuticals Translational Medicine
Bayer AG
Müllerstraße 178
13353 Berlin
Burkhard Kerlin
Medical Writing
Bayer AG, Wuppertal
Friedrich-Ebert-Straße 217/333
42117 Wuppertal
Dr. med. Ingrid Klingmann
Board Director EUFEMED
Pharmaplex bvba
Av St-Hubert 51
1970 Wezembeek-Oppem
BELGIUM
Dr. med. Christine Klipping
Founder and CEO
dinox GmbH
Anklamer Straße 38
10115 Berlin
Dr. rer. nat. Andreas Kovar
Associate Vice President
Sanofi-Aventis Deutschland GmbH
Industriepark Hoechst
Geb. H831
65926 Frankfurt a. M.,
PD Dr. Fabian Müller
Head ECT Therapeutic Area CNS
Boehringer Ingelheim Pharma GmbH & Co. KG
Early Clinical Trials (ECT)
Birkendorfer Straße 65
88397 Biberach a. d. Riß
Dr. rer. nat. Maike Narten
Medical Writer
SocraTec R&D GmbH
Im Setzling 35
61440 Oberursel
Dr. med. vet. Stephanie Plassmann
PreClinical Safety (PCS) Consultants Ltd
Nauenstrasse 49
4052 Basel
SWITZERLAND
Dr. med. Jens Rengelshausen
Ärztlicher Mitarbeiter
Uniklinik RWTH Aachen
Institut für Arbeits-
Sozial- und Umweltmedizin
Pauwelsstraße 30
52074 Aachen
Robert Schultz-Heienbrok
Director Scientific Services
Charité Research Organisation GmbH
Charitéplatz 1
10117 Berlin
Bettina Ziegele, M.A.
Stakeholder Cooperations & International Affairs America
Paul-Ehrlich-Institut, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel
Paul-Ehrlich-Straße 51-59
63225 Langen
Dr. Michael Zühlsdorf
Translational Science Consulting
Bonn
